Preclinical Evidence is a recurring topic in our peptide coverage. This hub collects every article tagged Preclinical Evidence, newest first, each evidence-graded and tied to real, verifiable sources.
A clinical monograph on Bronchogen — the lung/bronchial 'bioregulator' tetrapeptide (ADEL/AEDL) from the Khavinson short-peptide program. Promising preclinical biology, zero human efficacy or safety trials, and an unapproved 2026 legal status.
A clinical monograph on the arginate (di-L-arginine) salt of BPC-157 — the same peptide with an arginine counterion. The storage and gastric-acid stability advantage is real; the headline oral-bioavailability claims are unproven marketing.
A clinical monograph on adipotide (FTPP) — the fat-targeted proapoptotic peptide that shrinks white fat by ablating its blood supply. Dramatic preclinical fat loss, no completed human trial, and a documented kidney-toxicity signal.
A clinical monograph on 5-Amino-1MQ — the small-molecule NNMT inhibitor sold as a fat-loss and longevity 'peptide.' Despite its peptide-channel marketing, it is not a peptide, and every efficacy finding is preclinical.
A clinical monograph on BPC-157 — the stable gastric pentadecapeptide marketed for tendon, gut and wound healing. Deep preclinical data, no completed human RCT, and an unsettled 2026 legal status.
Preclinical Evidence is a topic our editors cover across the site. This hub aggregates the related, evidence-graded guidance.
This hub updates automatically whenever a new article is tagged Preclinical Evidence, so the latest coverage appears first.
Yes. Every article here grades its efficacy claims A-D and cites real, verifiable studies, regulatory documents or trial registries.
The majority of compounds documented here are not approved by the FDA for human use. Approved drugs (e.g. semaglutide, tirzepatide) are noted explicitly and require a licensed prescriber.
Many peptides — including BPC-157 and GHK-Cu in injectable form — are sold strictly "for research use only — not for human consumption." Purity, identity, and dosing of such products are not regulated or guaranteed.
Several compounds are banned in competitive sport under the WADA Prohibited List. Athletes risk sanction regardless of intent or formulation.
Always consult a qualified, licensed healthcare professional before considering any compound. Individual risk depends on your full medical context.
This content is for informational and educational purposes only · No physician–patient relationship is created · Evidence grades reflect published data as of the stated revision and may change.